Literature DB >> 639959

Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia.

I M Modlin, S R Bloom, S Mitchell.   

Abstract

Vasoactive intestinal polypeptide (VIP) is released into the portal circulation in large quantities by ischaemic bowel. In view of its known high concentration in the gut and potent vasoactive properties it may well be implicated in the pathogenesis of the serious haemodynamic changes produced by gut ischaemia.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 639959     DOI： 10.1007/BF01935976

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  3 in total

1.  Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

Authors:  M G Bryant; M M Polak; I Modlin; S R Bloom; R H Albuquerque; A G Pearse
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

2.  Release of vasoactive intestinal polypeptide (VIP) by electric stimulation of the vagal nerves.

Authors:  O B Schaffalitzky de Muckadell; J Fahrenkrug; J J Holst
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

3.  Release of VIP by calcium stimulation.

Authors:  A M Ebeid; P Murray; P B Soeters; J E Fischer
Journal:  Am J Surg       Date:  1977-01       Impact factor: 2.565
  3 in total
  16 in total

Review 1.  Aetiology of running-related gastrointestinal dysfunction. How far is the finishing line?

Authors:  S M Gil; E Yazaki; D F Evans
Journal:  Sports Med       Date:  1998-12       Impact factor: 11.136

Review 2.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

Review 3.  Gastrointestinal symptoms during exercise. The effect of fluid supplementation.

Authors:  H P Peters; L M Akkermans; E Bol; W L Mosterd
Journal:  Sports Med       Date:  1995-08       Impact factor: 11.136

Review 4.  Is the gut an athletic organ? Digestion, absorption and exercise.

Authors:  F Brouns; E Beckers
Journal:  Sports Med       Date:  1993-04       Impact factor: 11.136

5.  The pharmacokinetics of VIP in dog and pig.

Authors:  S J Mitchell; I M Modlin; A A D'Sa Barros; S R Bloom
Journal:  Experientia       Date:  1982-09-15

6.  Activation of Cl secretion during chemical hypoxia by endogenous release of adenosine in intestinal epithelial monolayers.

Authors:  J B Matthews; K J Tally; J A Smith; A J Zeind; B J Hrnjez
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Influence of vasoactive intestinal polypeptide on net water flux and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum.

Authors:  E Beubler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

8.  Gastrointestinal disturbances in marathon runners.

Authors:  C Riddoch; T Trinick
Journal:  Br J Sports Med       Date:  1988-06       Impact factor: 13.800

9.  Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.

Authors:  S Kishimoto; H Kobayashi; S Shimizu; K Haruma; T Tamaru; G Kajiyama; A Miyoshi
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

10.  The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP).

Authors:  Z Gimmon; R F Murphy; M H Chen; C A Nachbauer; J E Fischer; S N Joffe
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.